X0508 4/A 2022-02-03 2022-02-03 false 0001603756 Axonics, Inc. AXNX 0001756438 Dearen Danny L. 26 TECHNOLOGY DRIVE IRVINE CA 92618 false true false false President & CFO false Common Stock 2022-02-03 4 M false 36919.00 0.00 A 57919.00 D Common Stock 2022-02-03 4 S false 17737.00 48.2103 D 40182.00 D Common Stock 2022-02-03 4 S false 947.00 49.0347 D 39235.00 D This amendment is being filed to address an error in reporting the amount of securities beneficially owned following reported transactions on February 3, 2022. Accordingly, this amendment is being filed to amend and restate this line from the Original Form 4 in its entirety. This Form 4 acts as an amendment for all subsequently filed Form 4s. Shares of Issuer's common stock sold to cover the reporting person's tax obligation in connection with the conversion of the Performance-Based Restricted Stock Units disclosed herein. This transaction was executed in multiple trades at prices ranging from $47.76 to $48.75. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $48.78 to $49.14. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. /s/ Danny L. Dearen 2023-10-03